APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Non-Invasive Prenatal Testing Kit

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Non-Invasive Prenatal Testing Kit Market Outlook and Growth Opportunities 2026

Report ID 17401761042 January 2026194 pages

Choose your research edition.

Industry ResearchNon-Invasive Prenatal Testing Kit Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Non-Invasive Prenatal Testing Kit Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Non-Invasive Prenatal Testing Kit Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non-Invasive Prenatal Testing Kit Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Non-Invasive Prenatal Testing Kit Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Non-Invasive Prenatal Testing Kit market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Non-Invasive Prenatal Testing Kit is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Non-Invasive Prenatal Testing Kit is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Non-Invasive Prenatal Testing Kit is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Non-Invasive Prenatal Testing Kit market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Non-Invasive Prenatal Testing Kit market include Berry Genomics, BGI Genomics, Illumina, LabCorp, Natera, Quest Diagnostics, Sequenom and Roche, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Non-Invasive Prenatal Testing Kit market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Non-Invasive Prenatal Testing Kit and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Non-Invasive Prenatal Testing Kit revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Non-Invasive Prenatal Testing Kit market.

Non-Invasive Prenatal Testing Kit Segment by Company

Berry Genomics

BGI Genomics

Illumina

LabCorp

Natera

Quest Diagnostics

Sequenom

Roche

Non-Invasive Prenatal Testing Kit Segment by Type

High & Average Risk

Low Risk

Non-Invasive Prenatal Testing Kit Segment by Application

0-12 weeks

13-24 weeks

25-36 weeks

Non-Invasive Prenatal Testing Kit Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Non-Invasive Prenatal Testing Kit status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Non-Invasive Prenatal Testing Kit key companies, revenue, market share, and recent developments.

3. To split the Non-Invasive Prenatal Testing Kit breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Non-Invasive Prenatal Testing Kit market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Non-Invasive Prenatal Testing Kit significant trends, drivers, influence factors in global and regions.

6. To analyze Non-Invasive Prenatal Testing Kit competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-Invasive Prenatal Testing Kit market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-Invasive Prenatal Testing Kit and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-Invasive Prenatal Testing Kit.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Non-Invasive Prenatal Testing Kit industry.

Chapter 3: Detailed analysis of Non-Invasive Prenatal Testing Kit company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Non-Invasive Prenatal Testing Kit in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Non-Invasive Prenatal Testing Kit in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Non-Invasive Prenatal Testing Kit Industry Trends Table 2. Non-Invasive Prenatal Testing Kit Industry Drivers Table 3. Non-Invasive Prenatal Testing Kit Industry Opportunities and Challenges Table 4. Non-Invasive Prenatal Testing Kit Industry Restraints Table 5. Global Non-Invasive Prenatal Testing Kit Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Non-Invasive Prenatal Testing Kit Revenue Share by Company (2021-2026) Table 7. Global Non-Invasive Prenatal Testing Kit Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Non-Invasive Prenatal Testing Kit Key Company Manufacturing Base & Headquarters Table 9. Global Non-Invasive Prenatal Testing Kit Company, Product Type & Application Table 10. Global Non-Invasive Prenatal Testing Kit Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Non-Invasive Prenatal Testing Kit by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of High & Average Risk Table 15. Significant Companies of Low Risk Table 16. Global Non-Invasive Prenatal Testing Kit Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Non-Invasive Prenatal Testing Kit Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Non-Invasive Prenatal Testing Kit Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Non-Invasive Prenatal Testing Kit Sales Value Share by Type (2021-2026) Table 20. Global Non-Invasive Prenatal Testing Kit Sales Value Share by Type (2027-2032) Table 21. Significant Companies of 0-12 weeks Table 22. Significant Companies of 13-24 weeks Table 23. Significant Companies of 25-36 weeks Table 24. Global Non-Invasive Prenatal Testing Kit Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Non-Invasive Prenatal Testing Kit Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Non-Invasive Prenatal Testing Kit Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Non-Invasive Prenatal Testing Kit Sales Value Share by Application (2021-2026) Table 28. Global Non-Invasive Prenatal Testing Kit Sales Value Share by Application (2027-2032) Table 29. Global Non-Invasive Prenatal Testing Kit Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Non-Invasive Prenatal Testing Kit Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Non-Invasive Prenatal Testing Kit Sales Value Share by Region (2021-2026) Table 32. Global Non-Invasive Prenatal Testing Kit Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Non-Invasive Prenatal Testing Kit Sales Value Share by Region (2027-2032) Table 34. Global Non-Invasive Prenatal Testing Kit Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Non-Invasive Prenatal Testing Kit Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Non-Invasive Prenatal Testing Kit Sales Value Market Share by Country (2021-2026) Table 37. Global Non-Invasive Prenatal Testing Kit Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Non-Invasive Prenatal Testing Kit Sales Value Market Share by Country (2027-2032) Table 39. Berry Genomics Company Information Table 40. Berry Genomics Business Overview Table 41. Berry Genomics Non-Invasive Prenatal Testing Kit Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Berry Genomics Non-Invasive Prenatal Testing Kit Product Portfolio Table 43. Berry Genomics Recent Development Table 44. BGI Genomics Company Information Table 45. BGI Genomics Business Overview Table 46. BGI Genomics Non-Invasive Prenatal Testing Kit Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. BGI Genomics Non-Invasive Prenatal Testing Kit Product Portfolio Table 48. BGI Genomics Recent Development Table 49. Illumina Company Information Table 50. Illumina Business Overview Table 51. Illumina Non-Invasive Prenatal Testing Kit Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Illumina Non-Invasive Prenatal Testing Kit Product Portfolio Table 53. Illumina Recent Development Table 54. LabCorp Company Information Table 55. LabCorp Business Overview Table 56. LabCorp Non-Invasive Prenatal Testing Kit Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. LabCorp Non-Invasive Prenatal Testing Kit Product Portfolio Table 58. LabCorp Recent Development Table 59. Natera Company Information Table 60. Natera Business Overview Table 61. Natera Non-Invasive Prenatal Testing Kit Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Natera Non-Invasive Prenatal Testing Kit Product Portfolio Table 63. Natera Recent Development Table 64. Quest Diagnostics Company Information Table 65. Quest Diagnostics Business Overview Table 66. Quest Diagnostics Non-Invasive Prenatal Testing Kit Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Quest Diagnostics Non-Invasive Prenatal Testing Kit Product Portfolio Table 68. Quest Diagnostics Recent Development Table 69. Sequenom Company Information Table 70. Sequenom Business Overview Table 71. Sequenom Non-Invasive Prenatal Testing Kit Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Sequenom Non-Invasive Prenatal Testing Kit Product Portfolio Table 73. Sequenom Recent Development Table 74. Roche Company Information Table 75. Roche Business Overview Table 76. Roche Non-Invasive Prenatal Testing Kit Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Roche Non-Invasive Prenatal Testing Kit Product Portfolio Table 78. Roche Recent Development Table 79. Research Programs/Design for This Report Table 80. Authors List of This Report Table 81. Secondary Sources Table 82. Primary Sources List of Figures Figure 1. Non-Invasive Prenatal Testing Kit Product Image Figure 2. Global Non-Invasive Prenatal Testing Kit Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non-Invasive Prenatal Testing Kit Market Size (2021-2032) & (US$ Million) Figure 4. Global Non-Invasive Prenatal Testing Kit Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. High & Average Risk Image Figure 8. Low Risk Image Figure 9. Global Non-Invasive Prenatal Testing Kit Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Non-Invasive Prenatal Testing Kit Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Non-Invasive Prenatal Testing Kit Sales Value Share by Type (2021-2032) Figure 12. 0-12 weeks Image Figure 13. 13-24 weeks Image Figure 14. 25-36 weeks Image Figure 15. Global Non-Invasive Prenatal Testing Kit Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Non-Invasive Prenatal Testing Kit Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Non-Invasive Prenatal Testing Kit Sales Value Share by Application (2021-2032) Figure 18. Global Non-Invasive Prenatal Testing Kit Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Non-Invasive Prenatal Testing Kit Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Non-Invasive Prenatal Testing Kit Sales Value (2021-2032) & (US$ Million) Figure 21. North America Non-Invasive Prenatal Testing Kit Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Non-Invasive Prenatal Testing Kit Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Non-Invasive Prenatal Testing Kit Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Non-Invasive Prenatal Testing Kit Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Non-Invasive Prenatal Testing Kit Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Non-Invasive Prenatal Testing Kit Sales Value (2021-2032) & (US$ Million) Figure 27. South America Non-Invasive Prenatal Testing Kit Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Non-Invasive Prenatal Testing Kit Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Non-Invasive Prenatal Testing Kit Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Non-Invasive Prenatal Testing Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Non-Invasive Prenatal Testing Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Non-Invasive Prenatal Testing Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Non-Invasive Prenatal Testing Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Non-Invasive Prenatal Testing Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Non-Invasive Prenatal Testing Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Non-Invasive Prenatal Testing Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Non-Invasive Prenatal Testing Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Non-Invasive Prenatal Testing Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Non-Invasive Prenatal Testing Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Non-Invasive Prenatal Testing Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Non-Invasive Prenatal Testing Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Non-Invasive Prenatal Testing Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Non-Invasive Prenatal Testing Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Non-Invasive Prenatal Testing Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Non-Invasive Prenatal Testing Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Non-Invasive Prenatal Testing Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Non-Invasive Prenatal Testing Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Non-Invasive Prenatal Testing Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Non-Invasive Prenatal Testing Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Non-Invasive Prenatal Testing Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Non-Invasive Prenatal Testing Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Non-Invasive Prenatal Testing Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Non-Invasive Prenatal Testing Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Non-Invasive Prenatal Testing Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Non-Invasive Prenatal Testing Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Non-Invasive Prenatal Testing Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Non-Invasive Prenatal Testing Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Non-Invasive Prenatal Testing Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Non-Invasive Prenatal Testing Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Non-Invasive Prenatal Testing Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Non-Invasive Prenatal Testing Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Non-Invasive Prenatal Testing Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Non-Invasive Prenatal Testing Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Non-Invasive Prenatal Testing Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Non-Invasive Prenatal Testing Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Non-Invasive Prenatal Testing Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Non-Invasive Prenatal Testing Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Non-Invasive Prenatal Testing Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Non-Invasive Prenatal Testing Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Non-Invasive Prenatal Testing Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Non-Invasive Prenatal Testing Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Non-Invasive Prenatal Testing Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Non-Invasive Prenatal Testing Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Non-Invasive Prenatal Testing Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Non-Invasive Prenatal Testing Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Non-Invasive Prenatal Testing Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Non-Invasive Prenatal Testing Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Non-Invasive Prenatal Testing Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Non-Invasive Prenatal Testing Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Non-Invasive Prenatal Testing Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Non-Invasive Prenatal Testing Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Non-Invasive Prenatal Testing Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Non-Invasive Prenatal Testing Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Non-Invasive Prenatal Testing Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Non-Invasive Prenatal Testing Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Non-Invasive Prenatal Testing Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Non-Invasive Prenatal Testing Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Non-Invasive Prenatal Testing Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Non-Invasive Prenatal Testing Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Non-Invasive Prenatal Testing Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Non-Invasive Prenatal Testing Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Non-Invasive Prenatal Testing Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Non-Invasive Prenatal Testing Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Non-Invasive Prenatal Testing Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Non-Invasive Prenatal Testing Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Non-Invasive Prenatal Testing Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Non-Invasive Prenatal Testing Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Non-Invasive Prenatal Testing Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Non-Invasive Prenatal Testing Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Non-Invasive Prenatal Testing Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Non-Invasive Prenatal Testing Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Non-Invasive Prenatal Testing Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Non-Invasive Prenatal Testing Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Non-Invasive Prenatal Testing Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Non-Invasive Prenatal Testing Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Non-Invasive Prenatal Testing Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Non-Invasive Prenatal Testing Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Non-Invasive Prenatal Testing Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Non-Invasive Prenatal Testing Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Non-Invasive Prenatal Testing Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Non-Invasive Prenatal Testing Kit Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Non-Invasive Prenatal Testing Kit Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Non-Invasive Prenatal Testing Kit Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • High & Average Risk
  • Low Risk
Applications
  • 0-12 weeks
  • 13-24 weeks
  • 25-36 weeks
Companies covered
  • Berry Genomics
  • BGI Genomics
  • Illumina
  • LabCorp
  • Natera
  • Quest Diagnostics
  • Sequenom
  • Roche

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Non-Invasive Prenatal Testing Kit Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Non-Invasive Prenatal Testing Kit Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Non-Invasive Prenatal Testing Kit Market Dynamics
  1. 2.1 Non-Invasive Prenatal Testing Kit Industry Trends
  2. 2.2 Non-Invasive Prenatal Testing Kit Industry Drivers
  3. 2.3 Non-Invasive Prenatal Testing Kit Industry Opportunities and Challenges
  4. 2.4 Non-Invasive Prenatal Testing Kit Industry Restraints
3 Non-Invasive Prenatal Testing Kit Market by Company
  1. 3.1 Global Non-Invasive Prenatal Testing Kit Company Revenue Ranking in 2025
  2. 3.2 Global Non-Invasive Prenatal Testing Kit Revenue by Company (2021-2026)
  3. 3.3 Global Non-Invasive Prenatal Testing Kit Company Ranking (2024-2026)
  4. 3.4 Global Non-Invasive Prenatal Testing Kit Company Manufacturing Base and Headquarters
  5. 3.5 Global Non-Invasive Prenatal Testing Kit Company Product Type and Application
  6. 3.6 Global Non-Invasive Prenatal Testing Kit Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Non-Invasive Prenatal Testing Kit Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Non-Invasive Prenatal Testing Kit Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Non-Invasive Prenatal Testing Kit Market by Type
  1. 4.1 Non-Invasive Prenatal Testing Kit Type Introduction
  2. 4.1.1 High & Average Risk
  3. 4.1.2 Low Risk
  4. 4.2 Global Non-Invasive Prenatal Testing Kit Sales Value by Type
  5. 4.2.1 Global Non-Invasive Prenatal Testing Kit Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Non-Invasive Prenatal Testing Kit Sales Value by Type (2021-2032)
  7. 4.2.3 Global Non-Invasive Prenatal Testing Kit Sales Value Share by Type (2021-2032)
5 Non-Invasive Prenatal Testing Kit Market by Application
  1. 5.1 Non-Invasive Prenatal Testing Kit Application Introduction
  2. 5.1.1 0-12 weeks
  3. 5.1.2 13-24 weeks
  4. 5.1.3 25-36 weeks
  5. 5.2 Global Non-Invasive Prenatal Testing Kit Sales Value by Application
  6. 5.2.1 Global Non-Invasive Prenatal Testing Kit Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Non-Invasive Prenatal Testing Kit Sales Value by Application (2021-2032)
  8. 5.2.3 Global Non-Invasive Prenatal Testing Kit Sales Value Share by Application (2021-2032)
6 Non-Invasive Prenatal Testing Kit Regional Value Analysis
  1. 6.1 Global Non-Invasive Prenatal Testing Kit Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Non-Invasive Prenatal Testing Kit Sales Value by Region (2021-2032)
  3. 6.2.1 Global Non-Invasive Prenatal Testing Kit Sales Value by Region: 2021-2026
  4. 6.2.2 Global Non-Invasive Prenatal Testing Kit Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Non-Invasive Prenatal Testing Kit Sales Value (2021-2032)
  7. 6.3.2 North America Non-Invasive Prenatal Testing Kit Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Non-Invasive Prenatal Testing Kit Sales Value (2021-2032)
  10. 6.4.2 Europe Non-Invasive Prenatal Testing Kit Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Non-Invasive Prenatal Testing Kit Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Non-Invasive Prenatal Testing Kit Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Non-Invasive Prenatal Testing Kit Sales Value (2021-2032)
  16. 6.6.2 South America Non-Invasive Prenatal Testing Kit Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Non-Invasive Prenatal Testing Kit Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Non-Invasive Prenatal Testing Kit Sales Value Share by Country, 2025 VS 2032
7 Non-Invasive Prenatal Testing Kit Country-level Value Analysis
  1. 7.1 Global Non-Invasive Prenatal Testing Kit Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Non-Invasive Prenatal Testing Kit Sales Value by Country (2021-2032)
  3. 7.2.1 Global Non-Invasive Prenatal Testing Kit Sales Value by Country (2021-2026)
  4. 7.2.2 Global Non-Invasive Prenatal Testing Kit Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Non-Invasive Prenatal Testing Kit Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Non-Invasive Prenatal Testing Kit Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Non-Invasive Prenatal Testing Kit Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Non-Invasive Prenatal Testing Kit Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Non-Invasive Prenatal Testing Kit Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Non-Invasive Prenatal Testing Kit Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Non-Invasive Prenatal Testing Kit Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Non-Invasive Prenatal Testing Kit Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Non-Invasive Prenatal Testing Kit Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Non-Invasive Prenatal Testing Kit Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Non-Invasive Prenatal Testing Kit Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Non-Invasive Prenatal Testing Kit Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Non-Invasive Prenatal Testing Kit Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Non-Invasive Prenatal Testing Kit Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Non-Invasive Prenatal Testing Kit Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Non-Invasive Prenatal Testing Kit Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Non-Invasive Prenatal Testing Kit Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Non-Invasive Prenatal Testing Kit Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Non-Invasive Prenatal Testing Kit Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Non-Invasive Prenatal Testing Kit Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Non-Invasive Prenatal Testing Kit Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Non-Invasive Prenatal Testing Kit Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Non-Invasive Prenatal Testing Kit Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Non-Invasive Prenatal Testing Kit Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Non-Invasive Prenatal Testing Kit Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Non-Invasive Prenatal Testing Kit Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Non-Invasive Prenatal Testing Kit Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Non-Invasive Prenatal Testing Kit Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Non-Invasive Prenatal Testing Kit Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Non-Invasive Prenatal Testing Kit Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Non-Invasive Prenatal Testing Kit Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Non-Invasive Prenatal Testing Kit Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Non-Invasive Prenatal Testing Kit Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Non-Invasive Prenatal Testing Kit Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Non-Invasive Prenatal Testing Kit Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Non-Invasive Prenatal Testing Kit Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Non-Invasive Prenatal Testing Kit Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Non-Invasive Prenatal Testing Kit Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Non-Invasive Prenatal Testing Kit Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Non-Invasive Prenatal Testing Kit Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Non-Invasive Prenatal Testing Kit Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Non-Invasive Prenatal Testing Kit Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Non-Invasive Prenatal Testing Kit Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Non-Invasive Prenatal Testing Kit Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Non-Invasive Prenatal Testing Kit Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Non-Invasive Prenatal Testing Kit Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Non-Invasive Prenatal Testing Kit Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Non-Invasive Prenatal Testing Kit Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Non-Invasive Prenatal Testing Kit Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Non-Invasive Prenatal Testing Kit Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Non-Invasive Prenatal Testing Kit Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Non-Invasive Prenatal Testing Kit Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Non-Invasive Prenatal Testing Kit Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Non-Invasive Prenatal Testing Kit Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Non-Invasive Prenatal Testing Kit Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Non-Invasive Prenatal Testing Kit Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Non-Invasive Prenatal Testing Kit Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Non-Invasive Prenatal Testing Kit Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Non-Invasive Prenatal Testing Kit Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Non-Invasive Prenatal Testing Kit Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Non-Invasive Prenatal Testing Kit Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Non-Invasive Prenatal Testing Kit Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Non-Invasive Prenatal Testing Kit Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Non-Invasive Prenatal Testing Kit Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Non-Invasive Prenatal Testing Kit Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Non-Invasive Prenatal Testing Kit Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Non-Invasive Prenatal Testing Kit Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Non-Invasive Prenatal Testing Kit Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Non-Invasive Prenatal Testing Kit Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Non-Invasive Prenatal Testing Kit Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Non-Invasive Prenatal Testing Kit Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Non-Invasive Prenatal Testing Kit Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Non-Invasive Prenatal Testing Kit Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Non-Invasive Prenatal Testing Kit Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Non-Invasive Prenatal Testing Kit Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Non-Invasive Prenatal Testing Kit Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Non-Invasive Prenatal Testing Kit Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Non-Invasive Prenatal Testing Kit Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Non-Invasive Prenatal Testing Kit Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Non-Invasive Prenatal Testing Kit Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Non-Invasive Prenatal Testing Kit Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Non-Invasive Prenatal Testing Kit Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Non-Invasive Prenatal Testing Kit Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Non-Invasive Prenatal Testing Kit Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Berry Genomics
  2. 8.1.1 Berry Genomics Company Information
  3. 8.1.2 Berry Genomics Business Overview
  4. 8.1.3 Berry Genomics Non-Invasive Prenatal Testing Kit Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Berry Genomics Non-Invasive Prenatal Testing Kit Product Portfolio
  6. 8.1.5 Berry Genomics Recent Developments
  7. 8.2 BGI Genomics
  8. 8.2.1 BGI Genomics Company Information
  9. 8.2.2 BGI Genomics Business Overview
  10. 8.2.3 BGI Genomics Non-Invasive Prenatal Testing Kit Revenue and Gross Margin (2021-2026)
  11. 8.2.4 BGI Genomics Non-Invasive Prenatal Testing Kit Product Portfolio
  12. 8.2.5 BGI Genomics Recent Developments
  13. 8.3 Illumina
  14. 8.3.1 Illumina Company Information
  15. 8.3.2 Illumina Business Overview
  16. 8.3.3 Illumina Non-Invasive Prenatal Testing Kit Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Illumina Non-Invasive Prenatal Testing Kit Product Portfolio
  18. 8.3.5 Illumina Recent Developments
  19. 8.4 LabCorp
  20. 8.4.1 LabCorp Company Information
  21. 8.4.2 LabCorp Business Overview
  22. 8.4.3 LabCorp Non-Invasive Prenatal Testing Kit Revenue and Gross Margin (2021-2026)
  23. 8.4.4 LabCorp Non-Invasive Prenatal Testing Kit Product Portfolio
  24. 8.4.5 LabCorp Recent Developments
  25. 8.5 Natera
  26. 8.5.1 Natera Company Information
  27. 8.5.2 Natera Business Overview
  28. 8.5.3 Natera Non-Invasive Prenatal Testing Kit Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Natera Non-Invasive Prenatal Testing Kit Product Portfolio
  30. 8.5.5 Natera Recent Developments
  31. 8.6 Quest Diagnostics
  32. 8.6.1 Quest Diagnostics Company Information
  33. 8.6.2 Quest Diagnostics Business Overview
  34. 8.6.3 Quest Diagnostics Non-Invasive Prenatal Testing Kit Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Quest Diagnostics Non-Invasive Prenatal Testing Kit Product Portfolio
  36. 8.6.5 Quest Diagnostics Recent Developments
  37. 8.7 Sequenom
  38. 8.7.1 Sequenom Company Information
  39. 8.7.2 Sequenom Business Overview
  40. 8.7.3 Sequenom Non-Invasive Prenatal Testing Kit Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Sequenom Non-Invasive Prenatal Testing Kit Product Portfolio
  42. 8.7.5 Sequenom Recent Developments
  43. 8.8 Roche
  44. 8.8.1 Roche Company Information
  45. 8.8.2 Roche Business Overview
  46. 8.8.3 Roche Non-Invasive Prenatal Testing Kit Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Roche Non-Invasive Prenatal Testing Kit Product Portfolio
  48. 8.8.5 Roche Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst